Patent · US Active

Treatment of cancers with immunostimulatory HIV tat derivative polypeptides

US9663556B2 · kind B2 · utility

1Cited by
44References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2014
Grant dateMay 30, 2017
Priority date—
Expiry dateOct 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16071
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions comprising a Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) derivative polypeptide with increased immunostimulatory properties relative to the native Tat polypeptide, pharmaceutical compositions comprising the Tat derivative polypeptide, and methods of treating cancer using the Tat derivative polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.